Synapse - William Tap

Results (379)

Efficacy and safety of vimseltinib in tenosynovial giant cell tumour (TGCT): Phase II expansion

Meeting Abstract

Blay, J. Y.; Gelderblom, H.; Rutkowski, P.; Wagner, A.; van de Sande, M.; Gonzalez, A. F.; Stacchiotti, S.; Le Cesne, A.; Alcindor, T.; Serrano, C.; more...
Annals of Oncology (2022)

Fulltext@MSK | Save

Safety and efficacy of vimseltinib in tenosynovial giant cell tumour (TGCT): Long-term phase I update

Meeting Abstract

Gelderblom, H.; Abdul Razak, A.; Martin-Broto, J.; Wilky, B. A.; Rutkowski, P.; Narasimhan, S.; Vallee, M.; Sharma, M.; Ruiz-Soto, R.; Sherman, M. L.; more...
Annals of Oncology (2022)

Fulltext@MSK | Save

The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms

Journal Article

Dermawan, J. K.; Singer, S.; Tap, W. D.; Nacev, B. A.; Chi, P.; Wexler, L. H.; Ortiz, M. V.; Gounder, M.; Antonescu, C. R.
Modern Pathology (2022)

Fulltext@MSK | Save

Role of colony-stimulating factor 1 in the neoplastic process of tenosynovial giant cell tumor

Review

Tap, W. D.; Healey, J. H.
Tumor Biology (2022)

Fulltext@MSK | Save

MOTION: A randomized, phase 3, placebo-controlled, double-blind study of vimseltinib (DCC-3014) for the treatment of tenosynovial giant cell tumor

Meeting Abstract

Tap, W. D.; Wagner, A. J.; Sharma, M. G.; Vallee, M.; Michenzie, M. F.; Sherman, M. L.; Ruiz-Soto, R.; Stacchiotti, S.; van de Sande, M. A. J.; Gelderblom, H.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma

Meeting Abstract

Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Circulating tumor DNA (ctDNA) analyses of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor (GIST)

Meeting Abstract

Serrano, C.; Bauer, S.; Gómez-Peregrina, D.; Kang, Y. K.; Jones, R. L.; Rutkowski, P.; Mir, O.; Heinrich, M. C.; Tap, W. D.; Newberry, K.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A phase I/II trial of the PD-1 inhibitor retifanlimab (R) in combination with gemcitabine and docetaxel (GD) as first-line therapy in patients (Pts) with advanced soft-tissue sarcoma (STS)

Meeting Abstract

Rosenbaum, E.; Qin, L. X.; Thornton, K. A.; Movva, S.; Nacev, B. A.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Presence of immune infiltrates, increased expression of transposable elements, and viral response pathways in sarcoma associate with response to checkpoint inhibition